Abstract A very small population of choline acetyltransferase (ChAT) immunoreactive cells is observed in all layers of the adult hippocampus. This is the intrinsic source of the hippocampal cholinergic innervation, in addition to the well-established septo-hippocampal cholinergic projection. This study aimed at quantifying and identifying the origin of this small population of ChAT-immunoreactive cells in the hippocampus at early developmental stages, by culturing the fetal hippocampal neurons in serum-free culture and on a patternable, synthetic silane substrate N-1 [3-(trimethoxysilyl) propyl] diethylenetriamine. Using this method, a large proportion of glutamatergic (glutamate vesicular transporter, VGLUT1-immunoreactive) neurons, a small fraction of GABAergic (GABA-immunoreactive) neurons, and a large proportion of cholinergic (ChATimmunoreactive) neurons were observed in the culture. Interestingly, most of the glutamatergic neurons that expressed glutamate vesicular transporter (VGLUT1) also co-expressed ChAT proteins. On the contrary, when the cultures were double-stained with GABA and ChAT, colocalization was not observed. Neonatal and adult rat hippocampal neurons were also cultured to verify whether these more mature neurons also co-express VGLUT1 and ChAT proteins in culture. Colocalization of VGLUT1 and ChAT in these relatively more mature neurons was not observed. One possible explanation for this observation is that the neurons have the ability to synthesize multiple neurotransmitters at a very early stage of development and then with time follows a complex, combinatorial strategy of electrochemical coding to determine their final fate.
Introduction
In the adult mammalian hippocampus, choline acetyltransferase (ChAT) immunoreactive cells are rare but are observed in all layers of the hippocampus (Frotscher et al. 1986 ). This small number of ChAT-immunoreactive cells in the hippocampus are the intrinsic source of hippocampal cholinergic innervation, in addition to the well-established septo-hippocampal cholinergic projection (Vincent and McGeer 1981; Baisden et al. 1984; Frotscher and Leranth 1985; Frotscher et al. 1986; Gahwiler et al. 1987; Gilad et al. 1987; Ransmayr et al. 1989 Ransmayr et al. , 1992 Williams et al. 1989; Nilsson et al. 1992; De Lacalle et al. 1994; Linke et al. 1994; Ishimaru et al. 1995; Frazier et al. 1996; Schwegler et al. 1996; Sugaya et al. 1997; Ferencz et al. 2001; Sotty et al. 2003; Colom et al. 2005) . Interestingly, these endogenous cholinergic neurons, present in the hippocampus, have a functional role in the induction of long-term potentiation at mossy fiber-CA3 synapses (Maeda et al. 1994) . Furthermore, it has been observed that these small populations of cholinergic neurons in the rat hippocampus do not compensate for the loss of septo-hippocampal cholinergic fibers (Frotscher 1988) . However, the origin of these endogenous ChAT-immunoreactive cells in the hippocampus is not clear. In this study, the aim was to identify and quantify the origin of this rare population of ChAT-immunoreactive cells in cultured hippocampal neurons that were obtained from fetal, neonatal, and adult rats. A serum-free culture medium and patternable, synthetic silane substrate was utilized to grow the cells and perform the immunocytochemical studies. Our studies have shown that in the fetal rat, hippocampal neuron culture most of the glutamatergic neurons, which expressed glutamate vesicular transporter (VGLUT1), also coexpressed ChAT proteins. On the other hand, fetal hippocampal neurons, which expressed GABA, did not express ChAT. In cultured neonatal and adult hippocampal neurons, co-localization of VGLUT1 and ChAT proteins was not observed. Based on these findings, we are proposing that at a very early developmental stage, neurons have the ability to synthesize multiple neurotransmitters. The neurons, at this early stage of development, then follow a complex combinatorial strategy of electrochemical coding in order to determine their final fate. However, they lose this ability to synthesize multiple neurotransmitters as they mature.
Methods
Surface modification of the coverslips. Glass coverslips (Thomas Scientific 6661F52, 22×22 mm 2 , no. 1) were cleaned using an O 2 plasma cleaner (Harrick PDC-32G) for 20 min at 100 mTorr. The N-1 [3-(trimethoxysilyl) propyl] diethylenetriamine (DETA; United Chemical Technologies Inc., Bristol, PA, T2910KG) films were formed by the reaction of the cleaned surface with a 0.1% (v/v) mixture of the organosilane in freshly distilled toluene (Fisher T2904), according to Ravenscroft et al. (1998) . The DETA-coated coverslips were heated to just below the boiling point of toluene, rinsed with toluene, reheated to just below the boiling temperature, and then oven dried (Das et al. 2003 (Das et al. , 2005 (Das et al. , 2006 (Das et al. , 2007a .
Surface characterization of the coverslips after coating with DETA. Surfaces were characterized by contact angle measurements using an optical contact angle goniometer (KSV Instruments, Monroe, CT, Cam 200) and by X-ray photoelectron spectroscopy (XPS; ESCALab 220i-XL, FISONS, San Carlos, CA). The XPS survey scans, as well as high-resolution N 1s and C 1s scans, using monochromatic Al Kα excitation, were obtained similar to the previously reported results (Hickman et al. 1994; Ravenscroft et al. 1998; Das et al. 2007b, c) .
Fetal, neonatal and adult rat hippocampal neuron isolation and culture. The cell isolation procedures listed here are in agreement with and approved by the Animal Research Council of the University of Central Florida, which adheres to the IACUC policies.
Fetal hippocampal neuron culture. Eighteen-day-old fetuses were obtained from timed pregnant rats. The timed pregnant rats (fetal day18) were euthanized using carbon dioxide. After C-sectioning, the fetuses were collected in ice cold Hibernate E/B27/Glutamax™/ Antibiotic-Antimycotic. The fetuses were decapitated, and the whole brain was transferred into fresh cold Hibernate E/B27/Glutamax™/Antibiotic-Antimycotic. The hippocampi were isolated from the fetal brain and collected in a tube containing 1 ml of Hibernate E/B27/ Glutamax™/Antibiotic-Antimycotic. The fetal hippocampal neurons were obtained by triturating the tissue using a Pasteur pipette. The 1-ml cell suspension was layered over a 4-ml step gradient [Optipep diluted 0.505:0.495 (v/v) with Hibernate E/GlutaMAX™/AntibioticAntimycotic/B27 and then made to 15%, 20%, 25%, and 35% (v/v) in Hibernate E/GlutaMAX™/AntibioticAntimycotic/B27] followed by centrifugation for 15 min, using 800×g, at 4°C. This additional step helped to remove the debris that arose during dissection from the damaged cells. After centrifugation, one strong band of cells was obtained at the top. The pyramidal hippocampal neurons constituted this band with large somas. The cells were resuspended in culture medium (Neurobasal/B27/ Glutamax™/Antibiotic-Antimycotic) and plated at a density of 75 cells/mm 2 onto a DETA silane-coated substrate (Brewer et al. 1993; Stenger et al. 1993; Brewer 1995; Schaffner et al. 1995; Brewer and Price 1996; Brewer 1997; Stenger et al. 1998; Brewer 1999) . Half of the medium was changed after every 3-4 d.
Neonatal hippocampal neuron culture. Two-day-old neonatal rats were used for this culture. The neonatal rats were decapitated, and the whole brain was transferred into fresh cold Hibernate A/B27/Glutamax™/AntibioticAntimycotic. The hippocampi were isolated from the neonatal brain and collected in a tube containing 1 ml of Hibernate A/B27/Glutamax™/Antibiotic-Antimycotic. The neonatal hippocampal neurons were obtained by digesting the hippocampal tissue for 15 min in papain. The papain solution was prepared by dissolving 1 mg of papain in 1 ml of Hibernate A/B27/Glutamax™/AntibioticAntimycotic. The enzyme treatment was carried out in a shaking water bath at 37°C. After a 15-min treatment, the enzyme solution was washed with fresh Hibernate A/B27/Glutamax™/Antibiotic-Antimycotic and finally resuspended in 1 ml of fresh Hibernate A/B27/Glutamax™/ Antibiotic-Antimycotic. A single cell suspension was obtained by triturating the tissue using a Pasteur pipette. The 1-ml cell suspension was layered over a 4-ml step gradient [Optipep diluted 0.505: 0.495 (v/v) with Hibernate A/ GlutaMAX™ / Antibiotic-Antimycotic/ B27 and then made to 15%, 20%, 25%, and 35% (v/v) in Hibernate A/GlutaMAX™/Antibiotic-Antimycotic/ B27] followed by centrifugation for 15 min, using 800×g, at 4°C. This additional step helped to remove the debris that arose during dissection from the damaged cells. After centrifugation, one strong band of cells was obtained at the top. The pyramidal hippocampal neurons constituted this band with large somas. The cells were resuspended in culture medium (Neurobasal/B27/Glutamax™/AntibioticAntimycotic) and plated at a density of 75 cells/mm 2 on DETA silane-coated substrate (Brewer et al. 1993; Hickman et al. 1994; Brewer 1995; Schaffner et al. 1995; Brewer and Price 1996; Brewer 1999) . Half of the medium was changed after every 3-4 d.
Adult rat hippocampal neuron isolation and culture. Fourto six-month-old adult rats were used for the culture. The adult rats were decapitated, and the whole brain was transferred into fresh cold Hibernate A/B27/ Glutamax™/Antibiotic-Antimycotic. The hippocampi were isolated from the adult brain and collected in a tube containing 1 ml of Hibernate A/B27/Glutamax™/ Antibiotic-Antimycotic. The adult hippocampal neurons were obtained by digesting the hippocampal tissue for 15 min in papain. Papain solution was prepared by dissolving 1 mg of papain in 1 ml of Hibernate A/B27/ Glutamax™/Antibiotic-Antimycotic. The enzyme treatment was carried out in a shaking water bath at 37°C. After 15-min treatment, the enzyme solution was washed with fresh Hibernate A/B27/Glutamax™/Antibiotic-Antimycotic and finally resuspended in 1 ml of fresh Hibernate A/B27/ Glutamax™/Antibiotic-Antimycotic. A single cell suspension was obtained by triturating the tissue using a Pasteur pipette. The 1-ml cell suspension was layered over a 4-ml step gradient [Optipep diluted 0.505: 0.495 (v/v) with Hibernate A/GlutaMAX™/Antibiotic-Antimycotic/B27 and then made to 15%, 20%, 25%, and 35% (v/v) in Hibernate A/GlutaMAX™/Antibiotic-Antimycotic/ B27] followed by centrifugation for 15 min, using 800×g, at 4°C. After centrifugation, three bands of cells were obtained at the top. The neurons constituted the second and the third band. The cells were resuspended in culture medium [Neurobasal A/B27/basic FGF (5 ng/ml)/Glutamax™/ Antibiotic-Antimycotic] and plated at a density of 150 cells/mm 2 on DETA silane-coated substrate (Brewer et al. 1993; Stenger et al. 1993; Brewer 1995; Schaffner et al. 1995; Brewer and Price 1996; Brewer 1997; Stenger et al. 1998; Brewer 1999) . Half of the medium was changed after every 3-4 d. Immunocytochemistry. Four different antibodies were utilized, VGLUT1 (guinea pig anti-vesicular glutamate transport polyclonal antibody, cat. no. AB 5905, Chemicon, Temecula, CA, 1:100), ChAT (rabbit anti-choline acetyl-transferase affinity purified polyclonal antibody, cat. no. AB 5042, Chemicon, 1:100), GAD65 (anti-glutamate decarboxylase, 65 kDa Isoform, clone GAD-6, cat. no. 351R, Chemicon, 1:100), and GABA (anti-mouse GABA, clone 5A9, cat. no. MAB 316, Chemicon, 1:100) for the immunostaining. In preparation for staining with anti-VGLUT1, anti-ChAT, anti-GAD65, and anti-GABA antibodies, 80 μl of paraformaldehyde was added (prepared in PBS) to 2 ml of medium for 5 min. This reaction was performed while keeping the six-well plate on ice. After 5 min, the coverslips were rinsed free of medium with phosphate-buffered saline (PBS) and fixed for 20 min at room temperature with cold fixative (11.1 ml of formalin+89.9 ml of PBS+ 200 μl of glutaraldehyde+4 g of glucose). After 20 min, cells were permeabilized for 5 min with permeabilizing solution (50 mM lysine+0.5% Triton X-100+100 ml of PBS). After rinsing with PBS, the nonspecific sites were blocked with 5% normal donkey serum and 0.5% Triton X-100 in PBS. The cells were blocked for 2 h, and then the cells were incubated with the primary antibodies for 12 h at 4°C. After 12 h, the cells were rinsed free of blocking solution with PBS and then further incubated with the secondary antibodies. After rinsing four times in PBS, the cover slips were mounted with Vectashield mounting medium (H1000, Vector Laboratories, Burlingame, CA) onto slides. The coverslips were observed and photographed using a confocal microscope. Controls without primary antibody were negative. In the case of hippocampal slice samples, the whole hippocampal slice was processed in the similar manner as above. 
Results
This system uses a patternable (Stenger et al. 1993; Ravenscroft et al. 1998; Stenger et al. 1998) , nonbiological, cell growth promoting, organosilane substrate (DETA), coated on a glass surface, facilitating variable control and reproducibility of the growth surface (Schaffner et al. 1995; Ravenscroft et al. 1998; Das et al. 2003 Das et al. , 2004 Das et al. , 2007a . The quality of the surface modified coverslips used for the cell culture was evaluated using static contact angle measurements and XPS analysis as previously described (Hickman et al. 1994) . Stable contact angles (40.64°±2.9/ mean±SD) throughout the study indicated high reproducibility and quality of the DETA coatings and were similar to previously published results. Based on the ratio of the N (401 and 399 eV) and the Si 2p 3/2 peaks, XPS measurements indicated that a complete monolayer of DETA was formed on the coverslips.
In the first set of experiments, 20-d-old fetal hippocampal neuron cultures were stained separately with four different antibodies, glutamate vesicular transporter VGLUT1, GABA, GAD65, and ChAT. Based upon observation, 80% (n=6, where n is the total number of coverslips used for evaluation) of the cells were of glutamatergic (glutamate vesicular transporter, VGLUT1-immunoreactive) neurons (Fig. 1A, B) , a similar percentage of cells were cholinergic (ChATimmunoreactive) neurons (Fig. 1C, D) , and a very small fraction (15-20%, n=6) of cells were GABAergic (GABAand GAD65-immunoreactive) neurons (Fig. 1E-H) in the culture. Figure 1I -L indicates the double staining of the culture with anti-GABA and anti-VGLUT1 antibodies to view the network formation between inhibitory and excitatory hippocampal neurons in the culture.
The large proportion of ChAT-immunoreactive cells in the culture prompted a second set of experiments involving double staining of the cultures with VGLUT1 and ChAT antibodies. Interestingly, most of the glutamatergic neurons, which expressed glutamate vesicular transporter (VGLUT1), also co-expressed ChAT proteins ( Fig. 2A-H) . On the contrary, when the cultures were double-stained with GABA and ChAT, co-localization was not observed (Fig. 2I-L) . The GABA-positive fetal hippocampal neurons did not express ChAT. A similar colocalization of VGLUT1 and ChAT were obtained in fetal neurons cultured until day5 (data not shown) and day13 (Fig. 2H) . In order to verify whether this VGLUT1+ChAT colocalization was only seen in culture or whether it can also be observed in vivo, a whole fetal hippocampus slice was stained, and it was found that indeed VGLUT1 and ChAT proteins colocalized in vivo at day18 in the fetal hippocampus ( Fig. 2M-P) . In order to determine whether cultured neonatal neurons have the ability to co-express VGLUT1 and ChAT, a third set of experiments was performed. In this experiment, 13-d-old, cultured neonatal hippocampal neurons were double-stained with antibodies against VGLUT1 and ChAT proteins. In most of the neurons, no co-expression of VGLUT1 and ChAT (Fig. 3A-H) was observed. A very weak ChAT staining was observed in a very small population of neonatal neurons (Fig. 3I-L) .
Finally, to test whether adult hippocampal neurons have the ability to co-express VGLUT1 and ChAT in culture, 13-d-old cultured adult hippocampal neurons were double-stained with antibodies against VGLUT1 and ChAT proteins. No ChAT immunostaining was observed (Fig. 4A-L) .
Discussion
Our studies indicated that during fetal development of the mammalian hippocampus, most of the hippocampal neurons are equipped with the cellular machinery to synthesize both glutamate and acetylcholine. However, as the hippocampus matures, most of the neurons lose their ability to synthesize acetylcholine.
One of the possible explanations for this observation is that the neurons have the ability to express genes for synthesizing multiple transmitters at very early stages of development and then follow a combinatorial strategy of electrochemical coding to determine their final composition (Furshpan et al. 1976 (Furshpan et al. , 1986 Yang et al. 2002; Danik et al. 2005) . During the last two decades, studies have indicated that single neurons appear to use multiple, colocalized transmitter signals (Hokfelt et al. 1980; Bartfai et al. 1986) , and the final neurotransmitter phenotype of a neuron is decided either by the target organ, surrounding cells or by other unknown molecular switches (Johnson 1994; Asmus et al. 2000; Landis 2002 ). This combinatorial strategy at the synapse provides an individual neuron with extraordinary potential for combining signals not only at the single neuron level but also at the level of single synapse (Bartfai et al. 1986 ). Our studies indicate that fetal hippocampal neurons followed a similar combinatorial strategy during development; whereas at the fetal stage of development, glutamatergic hippocampal neurons synthesize both glutamate and acetylcholine. Previously, it has been reported that there is a frequent co-expression of vesicular transporter 1 gene, as well as co-expression with genes for choline acetyltransferase in different brain regions (Danik et al. 2005 ). However, whether these genes finally result in protein synthesis was not verified. In this study, the expression of the VGLUT1 and ChAT proteins was observed to be caused by these genes. Interestingly, the neonatal and adult neurons appeared to have lost the ability to synthesize ChAT.
Conclusions
If our initial hypothesis is correct, what remains to be answered is how this combinatorial strategy that is utilized by the VGLUT1+ChAT immunopositive hippocampal neurons at very early phases of development leads to intrinsic cholinergic signaling within the hippocampus. In addition, do glial cells or projections into the hippocampus from other brain areas play any role in determining the neurotransmitter phenotypes in the hippocampal drug development? Further investigation needs to be done to understand the as yet unknown molecular switch(es), which reduce the number of ChAT-immunoreactive cells in the mature hippocampus, as this now could have important implications for regeneration of neurons after disease or injury.
